share_log

Switzerland authorizes Moderna's COVID vaccine for 6-11 year olds

reuters ·  May 13, 2022 05:11  · Markets

May 13 (Reuters) - $Moderna(MRNA.US)$ said on Friday Swiss drugs regulator Swissmedic had authorized the use of its COVID-19 vaccine for children aged 6 to 11 years.

The approval is for the vaccine's two-dose series of 50 micro gram per dose, Moderna added.

(Reporting by Shivani Tanna in Bengaluru; Editing by Rashmi Aich)

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment